Form 8.3 - [AbbVie Inc.]
January 02 2020 - 9:58AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 31(st) December 2019
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,962,918 4.66322%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,962,918 4.66322%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 1,900 88.54
-------------- ----------------------------- -----------------------
Purchase 400 88.54
-------------- ----------------------------- -----------------------
Purchase 200 88.54
-------------- ----------------------------- -----------------------
Purchase 400 88.54
-------------- ----------------------------- -----------------------
Purchase 340 88.54
-------------- ----------------------------- -----------------------
Purchase 300 88.54
-------------- ----------------------------- -----------------------
Purchase 11,200 88.54
-------------- ----------------------------- -----------------------
Purchase 100 88.54
-------------- ----------------------------- -----------------------
Purchase 37 88.10
-------------- ----------------------------- -----------------------
Purchase 191 88.10
-------------- ----------------------------- -----------------------
Purchase 62 88.54
-------------- ----------------------------- -----------------------
Purchase 357 88.54
-------------- ----------------------------- -----------------------
Purchase 252,760 88.54
-------------- ----------------------------- -----------------------
Purchase 17,847 88.54
-------------- ----------------------------- -----------------------
Purchase 1,392 88.54
-------------- ----------------------------- -----------------------
Purchase 96 88.54
-------------- ----------------------------- -----------------------
Purchase 3,564 88.54
-------------- ----------------------------- -----------------------
Purchase 10,920 88.54
-------------- ----------------------------- -----------------------
Purchase 3,640 88.54
-------------- ----------------------------- -----------------------
Purchase 721 88.54
-------------- ----------------------------- -----------------------
Purchase 412 88.54
-------------- ----------------------------- -----------------------
Purchase 2,870 88.54
-------------- ----------------------------- -----------------------
Purchase 39 88.54
-------------- ----------------------------- -----------------------
Purchase 400 88.54
-------------- ----------------------------- -----------------------
Sale 2,000 87.93
-------------- ----------------------------- -----------------------
Sale 4,200 88.54
-------------- ----------------------------- -----------------------
Sale 400 88.54
-------------- ----------------------------- -----------------------
Sale 200 88.54
-------------- ----------------------------- -----------------------
Sale 5,800 88.54
-------------- ----------------------------- -----------------------
Sale 400 88.34
-------------- ----------------------------- -----------------------
Sale 400 88.54
-------------- ----------------------------- -----------------------
Sale 11,200 88.54
-------------- ----------------------------- -----------------------
Sale 103,100 88.54
-------------- ----------------------------- -----------------------
Sale 107,900 88.35
-------------- ----------------------------- -----------------------
Sale 4,600 88.54
-------------- ----------------------------- -----------------------
Sale 14,100 88.11
-------------- ----------------------------- -----------------------
Sale 400 88.54
-------------- ----------------------------- -----------------------
Sale 900 88.54
-------------- ----------------------------- -----------------------
Sale 37,400 88.54
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -------------------
Date of disclosure 01(st) January 2020
------------------------------------------------------- -------------------
Contact name Colin Fernandes
------------------------------------------------------- -------------------
Telephone number 020 33956221
------------------------------------------------------- -------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -------------------
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 31(st) December 2019
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,962,918 4.66322%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,962,918 4.66322%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 1,900 88.54
-------------- ----------------------------- -----------------------
Purchase 400 88.54
-------------- ----------------------------- -----------------------
Purchase 200 88.54
-------------- ----------------------------- -----------------------
Purchase 400 88.54
-------------- ----------------------------- -----------------------
Purchase 340 88.54
-------------- ----------------------------- -----------------------
Purchase 300 88.54
-------------- ----------------------------- -----------------------
Purchase 11,200 88.54
-------------- ----------------------------- -----------------------
Purchase 100 88.54
-------------- ----------------------------- -----------------------
Purchase 37 88.10
-------------- ----------------------------- -----------------------
Purchase 191 88.10
-------------- ----------------------------- -----------------------
Purchase 62 88.54
-------------- ----------------------------- -----------------------
Purchase 357 88.54
-------------- ----------------------------- -----------------------
Purchase 252,760 88.54
-------------- ----------------------------- -----------------------
Purchase 17,847 88.54
-------------- ----------------------------- -----------------------
Purchase 1,392 88.54
-------------- ----------------------------- -----------------------
Purchase 96 88.54
-------------- ----------------------------- -----------------------
Purchase 3,564 88.54
-------------- ----------------------------- -----------------------
Purchase 10,920 88.54
-------------- ----------------------------- -----------------------
Purchase 3,640 88.54
-------------- ----------------------------- -----------------------
Purchase 721 88.54
-------------- ----------------------------- -----------------------
Purchase 412 88.54
-------------- ----------------------------- -----------------------
Purchase 2,870 88.54
-------------- ----------------------------- -----------------------
Purchase 39 88.54
-------------- ----------------------------- -----------------------
Purchase 400 88.54
-------------- ----------------------------- -----------------------
Sale 2,000 87.93
-------------- ----------------------------- -----------------------
Sale 4,200 88.54
-------------- ----------------------------- -----------------------
Sale 400 88.54
-------------- ----------------------------- -----------------------
Sale 200 88.54
-------------- ----------------------------- -----------------------
Sale 5,800 88.54
-------------- ----------------------------- -----------------------
Sale 400 88.34
-------------- ----------------------------- -----------------------
Sale 400 88.54
-------------- ----------------------------- -----------------------
Sale 11,200 88.54
-------------- ----------------------------- -----------------------
Sale 103,100 88.54
-------------- ----------------------------- -----------------------
Sale 107,900 88.35
-------------- ----------------------------- -----------------------
Sale 4,600 88.54
-------------- ----------------------------- -----------------------
Sale 14,100 88.11
-------------- ----------------------------- -----------------------
Sale 400 88.54
-------------- ----------------------------- -----------------------
Sale 900 88.54
-------------- ----------------------------- -----------------------
Sale 37,400 88.54
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -------------------
Date of disclosure 02(nd) January 2020
------------------------------------------------------- -------------------
Contact name Colin Fernandes
------------------------------------------------------- -------------------
Telephone number 020 33956221
------------------------------------------------------- -------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -------------------
(END) Dow Jones Newswires
January 02, 2020 09:43 ET (14:43 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024
